BRIEF published on 01/27/2025 at 19:08, 10 months 8 days ago IMe's Ambitious Roadmap for 2025 Web3 Innovation IMe Platform Crypto Wallet $LIME Token LIME Game
PRESS RELEASE published on 01/27/2025 at 19:03, 10 months 8 days ago A Comprehensive Guide to iMe: Features, LIME Functions, and 2025 Roadmap iMe, the Telegram-based platform, combines advanced messaging with crypto, AI, and NFTs, defining Web3. Achieved milestones and ambitious roadmap for 2025 revealed Web3 NFTs Crypto IMe Telegram-based Platform
BRIEF published on 01/21/2025 at 17:47, 10 months 14 days ago IMe Sets Ambitious Course for 2025 with Web3 Innovations Web3 Innovation IMe Platform Crypto Wallet LIME Token 2025 Roadmap
PRESS RELEASE published on 01/21/2025 at 17:42, 10 months 14 days ago A Comprehensive Guide to iMe: Features, LIME Functions, and 2025 Roadmap iMe, a Telegram-based platform blending messaging with crypto, AI, and NFTs, showcases growth and innovations in 2024, setting ambitious goals for 2025 AI NFTs Crypto IMe Telegram-based Platform
Published on 12/05/2025 at 02:35, 2 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 42 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 25 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
